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IMMUNITY
Common 
Bacterium 
Induces Histamine 
Production in 
Neutrophils
Airway inflammation and constriction asso­
ciated with the release of histamine is a hall­
mark of asthma and allergies. Mast cells are 
considered the main producers of histamine.
1 
But  new  research  indicates  that  the  com­
mon environmental bacterium Pseudomonas 
aeruginosa can induce neutrophils, a type of 
white blood cell, to produce and release very 
high levels of histamine as well.
2 
Acute bacterial and viral infections often 
trigger serious asthma attacks that result in 
hospitalization, and many of these patients 
have elevated levels of neutrophils in their 
airways.
3  “We  suspected  that  neutro  phils 
may [produce] mediators that worsen air­
way  constriction,”  says  George  Caughey, 
chief of the Pulmonary and Critical Care 
Medicine  Section  at  the  Veterans  Affairs 
Medical  Center  and  a  professor  at  the 
University  of  California,  San  Francisco, 
who led the study.
A few years ago, Caughey’s laboratory 
studied mice infected with the bacterium 
Mycoplasma pulmonis and found that their 
neutrophils  released  histamine.
2  The 
researchers speculated that the more com­
mon  and  more  virulent  P.  aeruginosa—
which, like M. pulmonis, is associated with 
chronic airway infections—also may trig­
ger histamine production by neutrophils.
To  explore  the  connection,  the 
researchers  infected  mouse  neutrophils 
with  two  clinical  laboratory  strains  of 
P. aeruginosa. Strain PA103 quickly killed 
the  neutrophils,  and  no  extra  histamine 
was  produced.  The  other  strain,  PAO1, 
provoked  neutrophils  to  increase  hista­
mine production by as much as six times. 
However,  mast  cells  treated  with  PAO1 
produced no extra histamine. 
When mice were infected with PAO1, 
they  developed  bronchitis  and  pneumo­
nia,  and  lung  histamine  levels  rose  by 
about  three  times.  The  histamine  surge 
was  tracked  to  histidine  decarboxylase, 
a  key  enzyme  for  histamine  synthesis—
neutrophils  made  more  of  the  enzyme 
when infected with P. aeruginosa.
2  
The underlying causes of asthma and 
allergies are not well understood, but the 
findings  suggest  that  P.  aeruginosa  may 
trigger  inflammation  via  neutrophils. 
Patients with chronic airway diseases often 
experience cycles of bacterial infections fol­
lowed by inflammation.
4 Excess histamine 
generated  by  neutrophils  with  chronic 
P. aeruginosa infection could contribute to 
the narrowing of the airways observed in 
asthma, allergies, chronic bronchitis, cystic 
fibrosis, and other lung diseases, according 
to Caughey. 
The production of histamine by neutro­
phils “is a significant finding because his­
tamine is a major player in the respiratory 
tract. This opens the door for new ways to 
look at bacterial­associated allergic inflam­
mation,”  says  John  Wherry,  an  associate 
professor of microbiology at the University of 
Pennsylvania, Philadelphia. Understanding 
why only certain strains induce neutrophil 
histamine production “could reveal insights 
into  how  pathogens  evolve  to  evade  host 
immunity,” Wherry says.
Caughey  plans  to  test  whether  more 
strains of P. aeruginosa, other bacteria, and 
viruses also cause neutrophils to produce 
histamine. “The most common causes of 
severe asthma attacks are viruses,” he says. 
The next step would be to demonstrate that 
neutrophils  make  histamine  in  response 
to  microbial  infections  in  people.  If  this 
proves to be the case, Caughey says, “our 
research could improve the understanding 
of inflammation in bacterial infections and 
help us craft therapies for relief of inflam­
mation and its consequences.” 
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Observe always that everything is the result of change, and get used to thinking 
that there is nothing Nature loves so well as to change existing forms and make 
new ones of them. 
Marcus Aurelius (121–180), emperor of Rome
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Pseudomonas aeruginosa